Table 3.
Stem cell source | Benefits |
Drawbacks |
||
---|---|---|---|---|
Donor | Recipient | Donor | Recipient | |
BM | Lower risk of GvHD | More invasive HSC collection | ||
PBSC | No general anesthesia for collection; less discomfort and pain | Faster hematopoietic engraftment and immune reconstitution; enhanced GvL effect | Higher risk of GvHD | |
CB | Non-invasive | Lower risks of GvHD and relapse; rapid availability; increased level of HLA-disparity tolerated | Lower number of HSCs; slower immune reconstitution |
BM, bone marrow; PBSC, peripheral blood stem cells; CB, cord blood; GvHD, graft-versus-host disease; HSC, hematopoietic stem cell; GvL, graft-versus-leukemia, HLA, human leukocyte antigen.